Business Wire

Caranx Medical Announces FDA Submission of TAVIPILOT Soft: the World’s first AI Software for Real-time Intra-operative Guidance of Transcatheter Heart Valve Implantation

Share

Caranx Medical (“Caranx”), a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving procedure, today announced FDA submission of the world first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation.

The FDA submission marks a significant milestone of Caranx strategy towards planned market introduction of TAVIPILOT Soft by end of 2025.

“The team at Caranx has achieved an important milestone in the submission to the Food and Drug Administration, FDA. This extremely promising step paves the way to early commercialization of the TAVIPILOT Soft by end 2025. I am very excited about the real-time guidance of TAVI/TAVR, a key to accurate and precise positioning of the heart valve as well as the promotion of potentially more predictable and controlled valve deployment” says CEO of Caranx Jorgen Hansen

“Allowing a broader number of cardiologists, surgeons and interventional cardiology centers to perform complex procedures, such as TAVI, the Caranx AI-driven software and autonomous robot is at the heart of our mission of entrepreneurs and business builders to save lives and revolutionize medicine” says Philippe Pouletty, MD, founder of Caranx and CEO of Truffle Capital

“This first release of our TAVIPILOT software marks an important step toward AI-augmented procedures. Our software is designed to be user-friendly, ensuring that cardiologists and surgeons can integrate it seamlessly into their usual practice. TAVIPILOT Soft allows clinicians to position a prosthetic valve easily and with high precision, ensuring that more patients could benefit from a high quality of care.” says Caranx co-founder and CTO Pierre Berthet-Rayne

“TAVIPILOT soft is a breakthrough for TAVI procedures, providing millimetric precision using augmented reality. Clinicians use precise preoperative images (CT-scan) for the planning of TAVI. However, during the procedure, they rely only on fluoroscopy, which shows the anatomy indirectly (requiring contrast injection) and transiently. Accurately positioning the valve requires long training and experience. Our TAVIPILOT Soft identifies key heart anatomical features for precise valve placement and is expected to transform TAVI procedures for patients and clinicians” says Caranx co-founder and CMO Eric Sejor.

The TAVI procedure was introduced app. 20 years ago, and still critical challenges and long learning curves are faced by cardiologists and surgeons during these procedures for a precise and accurate delivery of the heart valve. While 300.000 TAVI procedures are performed annually in the USA and EU, 1.700.000 patients are in need of a TAVI procedure. According to Frost and Sullivan, the current TAVI market is $8Bn growing double digits annually. Caranx products could broadly increase the number of patients benefiting from TAVI.

TAVIPILOT Soft is an easy-to-use, AI-driven intra-operative software which tracks real-time anatomical and instrument landmarks. It enables precise and accurate heart valve positioning and delivery. TAVIPILOT Soft is expected to be a revolution for the transcatheter replacement of aortic valves, which is limited today because it is reserved for the most experienced cardiologists and centers. TAVIPILOT Soft is compatible with all cardiac Imaging Systems and will be compatible with principal TAVI heart valves on the market.

“At Caranx Medical, our vision extends to developing our Artificial Intelligence Platform, currently containing more than 5000 annotated multimodality images of CT, Fluoroscopy, Echo, data, etc. used to feed our AI algorithms and to revolutionize other cardiovascular indications, such as mitral and tricuspid valve replacements, reshaping the landscape of interventional medicine” says CEO of Caranx, Jorgen HANSEN

*****

About Caranx Medical

Backed by a team of top-tier experts, management team and supported by Truffle Capital, a renowned name in European biotech and MedTech investment, Caranx Medical is a French MedTech company, founded by Philippe Pouletty, MD, CEO of Truffle Capital, cofounded by CMO Eric Sejor, MD, and CTO Pierre Berthet-Rayne. Caranx has the ambition to become a global leader in AI and robotic assisted transcatheter heart valve implantation.

Subject to bringing TAVI PILOT Robotic solution with autonomous control to First in Human in 2025, Caranx ambition is to gradually commercialize its products and is poised for rapid growth.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250124801853/en/

Contacts

Armand Rigaudy
armandrigaudy@primatice.com
07 88 96 41 84

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Duravant to Acquire Pattyn, Provider of Packaging Automation Systems for Bulk and Industrial Applications7.2.2025 15:00:00 CET | Press Release

Duravant LLC (“Duravant”), a global engineered equipment and automation solutions provider to the food processing, packaging and material handling sectors, announced today that it has entered into a definitive agreement to acquire the Pattyn Group BV (‘Pattyn”), a designer and manufacturer of automation systems specializing in B2B packaging. Pattyn is recognized as the premier leader for delivering comprehensive automation solutions and value-added services for bag-in-box packaging applications. Headquartered in Bruges, Belgium, Pattyn has over 70 years of expertise in machinery design and turnkey systems for counting, weighing, filling, and packing technologies for food, ingredients, and various non-food sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250207117623/en/ “We are extremely excited to partner with Pattyn,” said Mike Kachmer, Chairman and CEO of Duravant. “Pattyn has a rich history delivering high quality

Leclanché and Pinnacle Advance Strategic Partnership – Milestone Reached with Successful Completion of Due Diligence7.2.2025 09:50:00 CET | Press Release

Ad hoc announcement pursuant to Art. 53 LR Leclanché SA (SIX: LECN), a global leader in energy storage solutions, specialised in heavy duty batteries for Marine and Rail customers, is pleased to announce that Pinnacle International Capital Limited has completed the legal, financial and technical due diligence of the Leclanché group to its satisfaction, thereby fulfilling a key condition on the way to the implementation of the strategic partnership. As a next step in the transaction, Pinnacle will conduct an engineering review. The engineering review aims to optimise the agreed business plan and investment. At the same time, Leclanché will be working through an agreed workplan to address the due diligence items that were identified, with the goal of improving the starting point for the strategic partnership and the investment by Pinnacle. Through this transformative strategic partnership, Pinnacle’s investment will help unlock the strategic growth funding required to support Leclanché’s

Salience Labs Closed Series A Round Led by Applied Ventures and ICM HPQC Fund7.2.2025 09:14:00 CET | Press Release

Salience Labs Limited, a leader in photonic solutions targeting connectivity for AI datacenter infrastructure, today announced the successful close of $30 million in Series A financing led by ICM HPQC Fund and Applied Ventures, LLC, the venture capital arm of Applied Materials, Inc., to further the development of its optical switches for large scale AI connectivity. Applied Ventures and ICM HPQC Fund are joined by Strategic Investment Fund, Braavos, and continued participation from existing investors Oxford Sciences Enterprises, Cambridge Innovation Capital, and leaders from the global semiconductor industry including Silicon Catalyst and Jalal Bagherli. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250207290130/en/ Image by Shabbir Bashar “What our customers want is a photonic switch to connect their AI clusters that is compatible with existing infrastructure while delivering high bandwidth, low latency and significant pow

Japan Sake and Shochu Makers Association Announces 2024 Sake Export Data: Record-High Exports to 80 Countries, Up 6% YoY7.2.2025 04:00:00 CET | Press Release

2024 Sake Export Performance This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250205320328/en/ More people around the world are enjoying Japanese sake (Photo: Business Wire) The Japan Sake and Shochu Makers Association (JSS) has released 2024 sake export data. The total export value reached JPY 43.5 billion, a +6% increase from the previous year, with 3.45 million cases (9L equivalent) shipped to a record 80 countries. Since 2020, export value has grown 1.8 times, the average unit price increased 1.3 times, and the number of export destinations expanded by 19. Premium sake markets have seen significant growth in the past five years. Regionally, Asia accounted for 61% of total export value but saw a slight decline YoY. However, South Korea recorded a notable 29% growth, while Thailand and Malaysia also performed well. North America saw a 27% increase, driven by fine-dining adoption. Western Europe grew 18% YoY, expanding 2.5 ti

DNIB.com Reports Internet Has 364.3 Million Domain Name Registrations at the End of the Fourth Quarter of 20246.2.2025 23:19:00 CET | Press Release

VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that, according to the latest Domain Name Industry Brief Quarterly Report from DNIB.com, the fourth quarter of 2024 closed with 364.3 million domain name registrations across all top-level domains (TLDs), an increase of 2.0 million domain name registrations, or 0.5% compared to the third quarter of 2024. Domain name registrations also increased by 4.4 million, or 1.2%, year over year. The .com and .net TLDs had a combined total of 169.0 million domain name registrations in the domain name base at the end of fourth quarter of 2024, a decrease of 0.5 million domain name registrations, or 0.3% compared to the third quarter of 2024. The .com and .net TLDs had a combined decrease of 3.7 million domain name registrations, or 2.1%, year over year. As of Dec. 31, 2024, the .com domain name base totaled 156.3 million domain name registrations and the .net domai

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye